Not medical advice. Selank is sold for research. This guide does not recommend dosing, diagnosis, or therapy.
Selank is listed in our catalogue under “Cognitive / Neuro.” In scientific publications it is discussed in technical language; this page translates the general themes into everyday wording while staying faithful to research-only framing.
One-paragraph overview from our research datasheet—still scientific, but faster to read than the full mechanism list below.
Selank is a synthetic tuftsin-derived heptapeptide anxiolytic that allosterically modulates GABAA receptors and upregulates hippocampal BDNF expression.
Many readers want context before diving into pathways. The list below summarises what researchers and reviewers discuss—cells, animals, and (for some drug-class molecules) formal clinical trials. It is not a promise of results for any individual.
“Reported” means described in the literature, not recommended for personal use. Our peptides are for laboratory research only.
Cognitive-related peptides are explored for stress-response pathways, neuronal signalling, and behaviour in animal models -not as treatments for human brain conditions.
Below are mechanistic bullet points as they appear in our product reference material -useful for researchers comparing pathways. They are not simplified health claims.
Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. ~5% degradation per year refrigerated. - see our storage guide for best practices on temperature, light, and shelf life.
Typical research dosing discussion (literature-style): 250–500 μg intranasal; 150–300 μg subcutaneous · Once daily intranasal (0.15% solution, 2–3 drops per nostril) · Complete plasma clearance within 10 minutes post-administration. C-terminal Pro-Gly-Pro extension substantially extends biological activity duration versus native tuftsin (t½ seconds). Intranasal route preferred for non-invasive CNS delivery. Metabolized rapidly in the liver and eliminated via renal excretion. Russian clinical doses: 150–300 μg intranasally, with anxiolytic effects observed within 10–15 minutes of administration.
For preparation, follow the step-by-step reconstitution guide and use the reconstitution calculator to confirm draw volumes. Review subcutaneous injection basics for technique, and always verify batch purity by reading the COA.
What is Selank in plain language?
Selank is a research peptide we catalogue under “Cognitive / Neuro.” This article explains how scientists discuss it in published literature and what study types usually appear—not as a consumer product claim.
Does this page give medical advice or dosing instructions for Selank?
No. Content is for laboratory and research literacy only. It does not diagnose, treat, or prevent disease, and is not a dosing guide.
Where can I see purity, variants, and pricing for Selank?
Use the “View product” button to open the canonical shop listing for Selank, where specifications and research SKU details are shown.
What about online case reports, before-and-after stories, or forum “logs” for Selank?
Those sources are not peer-reviewed evidence. This guide focuses on preclinical literature and, where relevant, formal clinical trial programmes for drug-class molecules. Anecdotes may be interesting culturally; they are not a safe basis for dosing or medical decisions.
Open the shop listing for variants, purity notes, and research SKU details.
View productAlso known as: Selank, TP-7, Selanc, TKPRPGP, Tuftsin Analogue, Thr-Lys-Pro-Arg-Pro-Gly-Pro, Selank Acetate, PL14736